Overview

A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

Status:
Completed
Trial end date:
2008-02-20
Target enrollment:
Participant gender:
Summary
This is a Phase I study to determine the effect of GW786034 (pazopanib) on P450 enzymes. This study will help determine which types of drugs may interact with GW786034.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline